Ernest Mui Selected Research

Ernest Mui Research Topics

8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 07/2014
4	Neoplasms (Cancer) 01/2022 - 01/2016
4	Infections 12/2012 - 10/2008
3	Toxoplasmosis 01/2016 - 05/2010
3	Congenital Toxoplasmosis 12/2011 - 05/2010
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
2	Inflammation (Inflammations) 07/2014 - 10/2008
1	Disease Resistance 11/2020
1	Hypersensitivity (Allergy) 05/2011
1	Cysts 04/2011
1	Alzheimer Disease (Alzheimer's Disease) 10/2008

4	VaccinesIBA 01/2016 - 05/2010
3	AndrogensIBA 01/2022 - 07/2014
2	LipidsIBA 01/2020 - 01/2016
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2020
2	LigandsIBA 01/2020 - 10/2008
2	Peptides (Polypeptides)IBA 01/2016 - 05/2010
2	Proteins (Proteins, Gene)FDA Link 04/2011 - 10/2008
1	cyclocreatineIBA 01/2022
1	CreatineIBA 01/2022
1	CreatinineIBA 01/2022
1	Phosphocreatine (Neoton)IBA 01/2022
1	creatine transporterIBA 01/2022
1	IsotopesIBA 01/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	PPAR gammaIBA 01/2021
1	2,4-dienoyl-CoA reductaseIBA 01/2020
1	CateninsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2018
1	EpitopesIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	12-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA 07/2014
1	CatecholaminesIBA 07/2014
1	Interleukin-12 (IL 12)IBA 12/2012
1	Interleukin-1 Receptor-Associated KinasesIBA 12/2012
1	AntibodiesIBA 12/2011
1	Thomsen-Friedenreich antibodiesIBA 04/2011
1	CytokinesIBA 02/2011
1	InflammasomesIBA 02/2011
1	Histocompatibility Antigens Class IIBA 05/2010
1	AminopeptidasesIBA 05/2010
1	Complement C1q (C1q Complement)IBA 10/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2008
1	Ligases (Synthetase)IBA 10/2008
1	Amyloid beta-PeptidesIBA 10/2008
1	UbiquitinIBA 10/2008
1	Oxidized LDL ReceptorsIBA 10/2008

6	Therapeutics 01/2022 - 07/2014
5	Castration 01/2022 - 01/2018